Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: 29. January| total n= 24,749
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: 29. January| total n= 24,749
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1076 1385
Bimekizumab 353 0
Brodalumab 580 0
Certolizumab 229 0
Efalizumab 35 0
Etanercept 312 72
Golimumab 25 0
Guselkumab 1803 0
Infliximab 102 1
Ixekizumab 1005 0
Risankizumab 1743 0
Secukinumab 2080 0
Tildrakizumab 1542 0
Ustekinumab 779 0
Apremilast 759 0
Ciclosporin 402 0
Fumaderm® 2694 0
Skilarence® 3310 0
Methotrexat 3922 0
Tofacitinib 2 0
Upadacitinib 5 0
Deucravacitinib 177 0
other systemics 356 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: 29. January| total n= 24,749
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: 29. January| total n= 24,749
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: 17. January| n= 1,171| updated monthly
Fig. 5) Registered PsoBest centers